Course Overview
|
Course Synopsis
|
This course is designed to develop understanding of the students to the fundamental and applied concepts of health biotechnology.
|
Course Learning Outcomes
|
After the successful completion of the course, students will be able to
- Understand and comprehend the scope of Health biotechnology
- The basic concepts of Health Biotechnology
|
Course Calendar
|
|
|
Week 01
|
1
|
1.What is biotechnology all about
|
|
2
|
2.Medical products developed by using biotechnology tools Antibiotics
|
|
5
|
5.Monoclonal antibodies
|
|
6
|
6.Bioengineered Tissues
|
|
7
|
7.Adult Stem Cell Therapy
|
|
8
|
8.Emerging Trends-Embryonic Stem Cells
|
|
10
|
10.RNA Interference Technology
|
|
11
|
11. Recombinant DNA Technology
|
Week 02
|
14
|
14.Liposome based drug delivery
|
|
16
|
16.Chromosomal Abnormalities
|
|
17
|
17.Chromosome Structural Abnormalities
|
|
18
|
18.Chromosome Numerical Abnormalities
|
|
19
|
19.Sex Chromosome Abnormalities
|
|
20
|
20.Single Gene Disorders
|
Week 03
|
28
|
28.Polygenic disorders: Diabetes
|
|
29
|
29.Diabetes Mellitus type 1
|
|
33
|
33.Cardiovascular Disease
|
Week 04
|
34
|
34.Mitochondrial Diseases
|
|
35
|
35.Mitochondrial homeostasis
|
|
37
|
37.Immunological Approaches To Detect Protein Biomarkers of Disease
|
|
39
|
39.Measuring Disease-Associated Proteins by Sandwich ELISA
|
|
40
|
40.Diagnosing Autoimmune Diseases by an Indirect ELISA
|
|
41
|
41. Immunoassay for infectious diseases
|
|
42
|
42.Protein Array to Detect Polygenic Disease
|
|
43
|
43.Immunoassay for Protein Conformation-specific Disorder
|
Week 05
|
44
|
44.DNA based approaches to diagnosis diseases
|
|
45
|
45.Allele specific Hybridization
|
|
46
|
46.Oligonucleotide ligation assay
|
|
48
|
48.Allele Specific PCR
|
|
50
|
50.Real-time PCR for infectious disease
|
|
51
|
51-DNA Sequences Technologies
|
|
52
|
52-Dideoxynucleotide Procedure
|
|
54
|
54-Sequencing Using Reversible Chain Terminators
|
Week 06
|
55
|
55-Sequencing by Ligation
|
|
56
|
56-The Immune Response
|
|
57
|
57-Functions of the Immune System
|
|
58
|
58-Innate immune system
|
|
59
|
59-Cellular network of innate immune system
|
|
61
|
61-Adaptive immune system
|
|
63
|
63-B lymphocytes and antibodies
|
|
64
|
64-Passive Memory and Active Memory
|
Week 07
|
67
|
67-Classifications of cell transplantation
|
|
68
|
68-Allogeneic cells,Xenogeneic cells
|
|
69
|
69-Organ Transplantation
|
|
70
|
70-Transgenic organisms
|
|
71
|
71-Production of Transgenic Animals
|
|
72
|
72-Transfer of Transgene in the Animal
|
|
73
|
73-Pronuclear Microinjection
|
|
74
|
74-DNA Transfer Through Virus
|
|
75
|
75-Embryonic Stem Cell Mediated Gene Transfer
|
|
76
|
76-Sperm-Mediated Transgenesis
|
Week 08
|
77
|
77-Somatic Cell Nuclear Transfer
|
|
78
|
78-Medical Applications of Transgenic Animals
|
|
79
|
79-Xenotransplantation
|
|
80
|
80-Therapeutic proteins
|
|
81
|
81-Recombinant human insulin
|
|
82
|
82-Recombinant human growth hormone
|
|
83
|
83-Recombinant blood clotting factor VIII
|
|
84
|
84-Recombinant tissue plasminogen activator
|
|
85
|
85-Recombinant erythropoietin
|
|
86
|
86-Significance of vaccines
|
|
87
|
87-Live attenuated vaccines
|
Week 09
|
88
|
88-Inactivated vaccines
|
|
89
|
89-Toxoid and Component vaccines
|
|
94
|
Biolgical Nanopore Sequencing
|
|
98
|
Principle of Drug delivery System
|
Week 10
|
99
|
Synthetic Pharmaceuticals
|
Week 11
|
111
|
Bioartificial Pancreas
|
|
115
|
Nucleic acid and stem cell-based therapies
|
|
117
|
Reproductive technologies I
|
|
118
|
Reproductive technologies II
|
|
119
|
Types of Gene Therapy
|
|
|
|